Individualized, Low-Dose, Fixed-Duration Lenalidomide Maintenance vs Observation After Front-Line Chemoimmunotherapy in CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Controlled Trial of Individualized, Low Dose, Fixed Duration Lenalidomide Maintenance Versus Observation After Frontline Chemo-Immunotherapy in CLL
Leukemia and Lymphoma 2021 Feb 21;[EPub Ahead of Print], N Jindal, DP Lad, P Malhotra, G Prakash, A Khadwal, A Jain, MS Sachdeva, S Sreedharanunni, S Naseem, N Varma, S VarmaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.